In AD patients, apoD expression is increased in the hippocampus, entorhinal cortex, pyramidal cells, and CSF when compared to controls (Terrisse et al., 1998; Kalman et al., 2000; Rassart et al., 2000; Belloir et al., 2001). Here, APOD is linked to Alzheimer disease.